Click here to access our MI Resources!

click here for larger video
Share in Our Pathways
to Success.

Great resource for smokers to motivate and coach them to quit and stay quit.

Do you ask your patients about smoking cessation?

	Every Visit
	Once a While
	Occasionally
	Never

Home

Featured Resources

Test Your Knowledge on Smoking Cessation!

This Learning from Self-Assessment^TM CME/CE activity was developed to assist you in examining your awareness of best practices in smoking cessation and your ability to apply those best practices.

Drug Interaction

This table lists drug interactions between tobacco smoke and medications.

Click here to access the table.

MedPage Today News: Smoking Tied to Worse Prostate Ca Survival

Men who are smokers when they receive a prostate cancer diagnosis have significantly worse survival and a greater risk of biochemical recurrence than neversmokers or those who had quit, researchers found.

Click here for the full story.

November 17 is the Great American Smokeout

The Great American Smokeout provides an opportunity to engage smokers in a dialogue about developing a plan to quit, helping them take an important step toward a healthier life. We encourage you to explore the more than 80 tools and educational activities on this site to help you and your patients tackle smoking cessation.

Performance Improvement: Get Serious

Want to get serious about changing your practice? CS2day Performance Improvement (PI) activities allow you to analyze how you personally, as well as your practice as a whole, are caring for current and past smokers.

Do Ask, Do Tell: The 5 A’s for Successful Smoking Cessation

According to the Clinical Practice Guideline: Treating Tobacco Use and Dependence 2008 Update, the 5 A’s (ask, advise, assess, assist, arrange) are an effective approach that clinicians should take to identify patients who smoke and to assist these patients with quitting.

New Posters Available

A set of 6 posters that address mental health and tobacco use are now available from the University of Wisconsin, Center for Tobacco Research and Intervention.

Click here to access the posters.

Motivational Interviewing Resources

As a part of our Building on Success project, the Physicians’ Institute coordinated two intensive workshops utilizing a Train-the-Trainer approach to promote the methods of Read more...

FDA Drug Safety Communication: Safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events

Written by Administrator | 28 October 2011

Safety Announcement

[10-24-2011] The U.S. Food and Drug Administration (FDA) has reviewed the results from two FDA-sponsored epidemiological studies that evaluated the risk of neuropsychiatric adverse events associated with the smoking cessation drug Chantix (varenicline).

Read the Full Story

FDA Drug Safety Communication: Chantix (varenicline)

17 June 2011

FDA Drug Safety Communication: Chantix (varenicline)
The U.S. Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix (varenicline) may be associated with a small, increased risk of certain cardiovascular adverse events in patients who have cardiovascular disease.

New Smoking Warnings - FDA

21 June 2011

This morning FDA announced the nine cigarette health warnings required to appear on every pack of cigarettes sold in the United States and in every cigarette advertisement. This bold measure is aimed at making sure that every American understands the dangers of smoking.

Performance Improvement

Educational Partners

Follow Us

The CS2day Story

Introducing QuitNet

Awards

Survey

Featured Resources

Test Your Knowledge on Smoking Cessation!

Drug Interaction

MedPage Today News: Smoking Tied to Worse Prostate Ca Survival

November 17 is the Great American Smokeout

Performance Improvement: Get Serious

Do Ask, Do Tell: The 5 A’s for Successful Smoking Cessation

New Posters Available

Motivational Interviewing Resources

FDA Drug Safety Communication: Safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events

FDA Drug Safety Communication: Chantix (varenicline)

New Smoking Warnings - FDA

More Articles...